| NCT Number | NCT07051811 |
| Lead Sponsor | Lepu Medical Technology (Beijing) Co., Ltd. |
| Conditions | Essential Hypertension |
| Enrollment | 213 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2027-12-31 (estimated) |
| Study Completion | 2029-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-07-04 |